Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00011624
DRKS00011624
Completed
Not Applicable

Risk factors for mortality and cardiovascular diseases in older adults in a primaray care setting – longitudinal analysis of the getABI-study

Ruhr-Universität Bochum0 sites6,880 target enrollmentJune 27, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRisk factors for mortality and cardiovascular diseasesI70.20

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Risk factors for mortality and cardiovascular diseases
Sponsor
Ruhr-Universität Bochum
Enrollment
6880
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2017
End Date
June 7, 2017
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •life expectancy more than six months

Exclusion Criteria

  • •missing legal competence

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Mortality and risk factors for cardiovascular and non-cardiovascular disease in Japanese with impaired glucose metabolism
JPRN-UMIN000036648Hiroshima Atomic Bomb Casualty Council19,248
Active, not recruiting
Phase 1
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-CZVIVUS, Inc.16,000
Active, not recruiting
Phase 1
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 14.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-SKVIVUS, Inc.16,000
Active, not recruiting
Not Applicable
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.0Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-GBVIVUS, Inc.16,000
Not yet recruiting
Not Applicable
cardiovascular complications in oncosurgeries- incidence and risk factorsHealth Condition 1: I219- Acute myocardial infarction, unspecifiedHealth Condition 2: I238- Other current complications following acute myocardial infarction
CTRI/2021/06/034184Regional Cancer Centre